Hyperion Biosystems

Founded in 2013 as an MIT “Tough Tech” spinout, Hyperion Biosystems (formerly C2Sense, Inc.) has created a suite of diagnostic devices that leverage our expertise in computer vision and physics-based algorithms to deliver exquisite performance at the lowest price. Our exceptional team of scientists and engineers have years of experience collaborating with market leaders in diagnostics and pharmaceuticals with the goal of minimizing the impact of disease and protecting people.